Kristine Ball

Dr. Kristine M.
Ball is an Independent Director at Oruka Therapeutics, Inc. She is on the Board of Directors at Enliven Therapeutics, Inc., Oruka Therapeutics, Inc. and National Kidney Foundation of Northern California.
Dr. Ball was previously employed as a President & Chief Executive Officer by Antiva Biosciences, Inc., a Chief Executive Officer & Director by Soteria Biotherapeutics, Inc., an Independent Director by Atreca, Inc., an Independent Director by Forty Seven LLC, a Chief Financial Officer & SVP-Corporate Strategy by Menlo Therapeutics, Inc., a Chief Financial Officer & Senior Vice President by Relypsa, Inc., a CFO, Senior VP-Administration & Finance by KAI Pharmaceuticals, Inc., a Vice President-Finance by Exelixis, Inc., and a Senior Manager by Ernst & Young LLP.
She received her undergraduate degree from Babson College.